Found: 53
Select item for more details and to access through your institution.
Palliation of Colorectal Cancer: New Possibilities and Challenges.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 566
- By:
- Publication type:
- Article
The Fakih/Padmanbhan Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 588
- By:
- Publication type:
- Article
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 768, doi. 10.1245/s10434-017-6082-1
- By:
- Publication type:
- Article
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0298808
- By:
- Publication type:
- Article
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 821, doi. 10.1007/s10637-019-00824-1
- By:
- Publication type:
- Article
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 836, doi. 10.1007/s10637-018-0560-6
- By:
- Publication type:
- Article
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 634, doi. 10.1007/s10637-017-0473-9
- By:
- Publication type:
- Article
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 235, doi. 10.1007/s10637-017-0439-y
- By:
- Publication type:
- Article
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 176, doi. 10.1007/s10637-015-0316-5
- By:
- Publication type:
- Article
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0121648
- By:
- Publication type:
- Article
Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113037
- By:
- Publication type:
- Article
Recurrent Pancreatic Adenocarcinoma After Pancreatic Resection.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 4, p. 989, doi. 10.1007/s00262-020-02701-w
- By:
- Publication type:
- Article
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1456, doi. 10.3390/cancers16081456
- By:
- Publication type:
- Article
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 719, doi. 10.3390/cancers12030719
- By:
- Publication type:
- Article
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent.
- Published in:
- Marine Drugs, 2014, v. 12, n. 9, p. 4833, doi. 10.3390/md12094833
- By:
- Publication type:
- Article
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 739, doi. 10.1007/s10637-014-0083-8
- By:
- Publication type:
- Article
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 345, doi. 10.1007/s10637-012-9820-z
- By:
- Publication type:
- Article
Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 1057, doi. 10.1007/s10637-010-9413-7
- By:
- Publication type:
- Article
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 340, doi. 10.1007/s10637-009-9383-9
- By:
- Publication type:
- Article
TNF-blockade in patients with advanced hormone refractory prostate cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 291, doi. 10.1007/s10637-006-5269-2
- By:
- Publication type:
- Article
WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.642328
- By:
- Publication type:
- Article
Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.614640
- By:
- Publication type:
- Article
HER2-Positive Metastatic Colorectal Cancer.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 5, p. 585, doi. 10.1007/s11864-024-01183-7
- By:
- Publication type:
- Article
Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.
- Published in:
- JOP Journal of the Pancreas, 2018, v. 19, n. 2, p. 75
- By:
- Publication type:
- Article
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.
- Published in:
- Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00120
- By:
- Publication type:
- Article
New Targeted Combination Therapies in NCCN Guideline for CRC Attack Various Pathways.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 5, p. 197
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 248, doi. 10.1016/j.clcc.2013.06.002
- By:
- Publication type:
- Article
Development of novel targeted agents in the treatment of metastatic colorectal cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 297, doi. 10.3816/CCC.2010.n.043
- By:
- Publication type:
- Article
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 951, doi. 10.1007/s00280-014-2426-8
- By:
- Publication type:
- Article
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 181, doi. 10.1007/s00280-008-0733-7
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 423, doi. 10.1007/s00280-007-0485-9
- By:
- Publication type:
- Article
Potent antitumor activity of cabozantinib, a c- MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 8, p. 1967, doi. 10.1002/ijc.29225
- By:
- Publication type:
- Article
Cetuximab or Bevacizumab With First-Line Chemotherapy in Advanced KRAS Wild-Type Colorectal Cancer: No Difference, but Not the Same.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 8, p. 966, doi. 10.1002/jcph.681
- By:
- Publication type:
- Article
Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 10, p. 1227, doi. 10.1002/mc.23251
- By:
- Publication type:
- Article
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 5, p. 1042, doi. 10.1002/cncr.27859
- By:
- Publication type:
- Article
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.
- Published in:
- Journal of Surgical Oncology, 2017, v. 115, n. 8, p. 1033, doi. 10.1002/jso.24613
- By:
- Publication type:
- Article
A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1409, doi. 10.1634/theoncologist.2018-0315
- By:
- Publication type:
- Article
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 172, doi. 10.1634/theoncologist.2015-0319
- By:
- Publication type:
- Article
Targeting the WNT Signaling Pathway in Cancer Therapeutics.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1189, doi. 10.1634/theoncologist.2015-0057
- By:
- Publication type:
- Article
Current Status of Src Inhibitors in Solid Tumor Malignancies.
- Published in:
- Oncologist, 2011, v. 16, n. 5, p. 566, doi. 10.1634/theoncologist.2010-0408
- By:
- Publication type:
- Article
Oxaliplatin-Induced Neuropathy in Colorectal Cancer.
- Published in:
- Journal of Oncology, 2011, p. 1, doi. 10.1155/2011/201593
- By:
- Publication type:
- Article